Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Nicholas G. Nickols"'
Autor:
Abhishek A. Solanki, Kevin Zheng, Alicia N. Skipworth, Lisa M. Robin, Ryan F. Leparski, Elizabeth Henry, Matthew Rettig, Joseph K. Salama, Timothy Ritter, Jeffrey Jones, Marcus Quek, Michael Chang, Alec M. Block, James S. Welsh, Aryavarta Kumar, Hann-Hsiang Chao, Albert C. Chen, Ronald Shapiro, Rhonda L. Bitting, Robert Kwon, William Stross, Lindsay Puckett, Yu-Ning Wong, Nicholas G. Nickols, Kimberly Carlson
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4781-4794 (2024)
The United States Veterans Affairs (VA) Health Care System has a strong history of conducting impactful oncology randomized clinical trials (RCTs). We developed a phase II/III RCT to test the use of metastasis-directed therapy in Veterans with oligom
Externí odkaz:
https://doaj.org/article/4a86707c77484767b9eb8ec89a024ca0
Publikováno v:
European Journal of Hybrid Imaging, Vol 7, Iss 1, Pp 1-9 (2023)
Abstract Rationale Prostate cancer treatment response may be automatically quantified using a molecular imaging analysis platform targeting prostate-specific membrane antigen (PSMA). Methods A retrospective analysis of patients with castration-sensit
Externí odkaz:
https://doaj.org/article/fb498082f99e4746856e514b1de08865
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is a molecular and functional imaging modality with better restaging accuracy over conventional imaging for detecting prostate cancer in me
Externí odkaz:
https://doaj.org/article/5f7ca3ca02c04642a2216fadf999faeb
Autor:
Nicholas G. Nickols, Matthew B. Goetz, Christopher J. Graber, Debika Bhattacharya, Guy Soo Hoo, Matthew Might, David B. Goldstein, Xinchen Wang, Rachel Ramoni, Kenute Myrie, Samantha Tran, Leila Ghayouri, Sonny Tsai, Michelle Geelhoed, Danil Makarov, Daniel J. Becker, Jun-Chieh Tsay, Melissa Diamond, Asha George, Mohammad Al-Ajam, Pooja Belligund, R. Bruce Montgomery, Elahe A. Mostaghel, Carlie Sulpizio, Zhibao Mi, Ellen Dematt, Joseph Tadalan, Leslie E. Norman, Daniel Briones, Christina E. Clise, Zachary W. Taylor, Jeffrey R. Huminik, Kousick Biswas, Matthew B. Rettig
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical an
Externí odkaz:
https://doaj.org/article/62f781dbd78244d99ccb944f53f3ca94
Autor:
Trudy C. Wu, MD, Michael Xiang, MD, PhD, Nicholas G. Nickols, MD, PhD, Stephen Tenn, PhD, Nzhde Agazaryan, PhD, John V. Hegde, MD, Michael L. Steinberg, MD, Minsong Cao, PhD, Amar U. Kishan, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 4, Pp 100944- (2022)
Purpose: To determine the effect of daily shifts based on rigid registration to intraprostatic markers on coverage of boost doses delivered to gross nodal disease for prostate cancer. Methods and Materials: Seventy-five cone beam computed tomographie
Externí odkaz:
https://doaj.org/article/9c4e147f398748a4a3515ec75bd0b383
Autor:
Jeremie Calais, Shaojun Zhu, Nader Hirmas, Matthias Eiber, Boris Hadaschik, Martin Stuschke, Ken Herrmann, Johannes Czernin, Amar U. Kishan, Nicholas G. Nickols, David Elashoff, Wolfgang P. Fendler
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background Definitive radiation therapy (dRT) is an effective initial treatment of intermediate-risk (IR) and high-risk (HR) prostate cancer (PCa). PSMA PET/CT is superior to standard of care imaging (CT, MRI, bone scan) for detecting region
Externí odkaz:
https://doaj.org/article/870c6b89399248c18205fcf9f3ba24e4
Autor:
Ting Martin Ma, James M. Lamb, Maria Casado, Xiaoyan Wang, T. Vincent Basehart, Yingli Yang, Daniel Low, Ke Sheng, Nzhde Agazaryan, Nicholas G. Nickols, Minsong Cao, Michael L. Steinberg, Amar U. Kishan
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Stereotactic body radiotherapy (SBRT) is becoming increasingly used in treating localized prostate cancer (PCa), with evidence showing similar toxicity and efficacy profiles when compared with longer courses of definitive radiatio
Externí odkaz:
https://doaj.org/article/4c13c8c705774beba723dddd67502241
Autor:
Audrey T. Dang, MD, Rebecca G. Levin-Epstein, MD, David Shabsovich, BS, Minsong Cao, PhD, Christopher King, PhD, MD, Fang-I. Chu, PhD, Constantine A. Mantz, MD, Kevin L. Stephans, MD, Chandana A. Reddy, MS, D. Andrew Loblaw, MD, Patrick Cheung, MD, Marta Scorsetti, MD, Luca Cozzi, PhD, Albert S. DeNittis, MD, Yue Wang, MD, Nicholas Zaorsky, MD, Nicholas G. Nickols, MD, PhD, Patrick A. Kupelian, MD, Michael L. Steinberg, MD, Amar U. Kishan, MD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 3, Pp 404-411 (2020)
Purpose: To establish the safety and efficacy of gantry-mounted linear accelerator-based stereotactic body radiation therapy (SBRT) for low- and intermediate-risk prostate cancer. Methods: We pooled 921 patients enrolled on 7 single-institution prosp
Externí odkaz:
https://doaj.org/article/b429538fa8f34619b7a82eb247040b8e
Autor:
Jesus E. Juarez, MD, Tahmineh Romero, MS, Constantine A. Mantz, MD, Abigail Pepin, MD, Nima Aghdam, MD, Simeng Suy, PhD, Michael L. Steinberg, MD, Rebecca G. Levin-Epstein, MD, Nicholas G. Nickols, MD, PhD, Irving D. Kaplan, MD, Robert M. Meier, MD, Huong T. Pham, MD, Patrick W. Linson, MD, Robert L. Hong, MD, Mark K. Buyyounouski, MD, Hilary P. Bagshaw, MD, Donald B. Fuller, MD, Alan J. Katz, MD, Andrew Loblaw, MD, Sean P. Collins, MD, PhD, Amar U. Kishan, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100759- (2021)
Purpose: To evaluate the safety of stereotactic body radiation therapy (SBRT) for prostate cancer in men with inflammatory bowel disease (IBD). Methods and Materials: We queried a consortium database for patients with IBD receiving SBRT for prostate
Externí odkaz:
https://doaj.org/article/0cfef0a7088e43cd9b104465d13bc9c8
Autor:
Neil R. Parikh, Claudia Huiza, Jill S. Patel, Sonny Tsai, Nathisha Kalpage, May Thein, Sage Pitcher, Steve P. Lee, Warren S. Inouye, Mark L. Jordan, Homayoon Sanati, Lida Jafari, Carol J. Bennett, Greg E. Gin, Amar U. Kishan, Robert E. Reiter, Michael Lewis, Ahmad Sadeghi, William J. Aronson, Isla P. Garraway, Matthew B. Rettig, Nicholas G. Nickols
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background The treatment paradigm for metastatic hormone-sensitive prostate cancer (mHSPC) patients is evolving. PET/CT now offers improved sensitivity and accuracy in staging. Recent randomized trial data supports escalated hormone therapy,
Externí odkaz:
https://doaj.org/article/e39a69cbcbfe4467bab111ddf5884090